New Data on HIV Prevention
![](/-/media/gilead-corporate/images/home/purpose-hiv-home-page.png?la=en&h=1066&w=1899&hash=C864869A5BD737D3631BCC944DB3966E)
In 2006, Gilead scientists began work on a potential long-acting HIV medication. After more than a decade of preclinical development and clinical trials, we’ve now announced topline results from a study investigating its use for HIV prevention.
Our Purpose
![A group of people sitting at a table](/-/media/gilead-corporate/images/home/stephaniecox3-min.jpg)
We’ve been taking on the world’s biggest health challenges for more than 35 years. We continue to set and achieve ambitious goals to create a healthier world for all people.
Our MissionRecent Stories
![Eyepiece of a microscope](/-/media/gilead-corporate/images/home/gilead_home_page_microscope.jpg)
Join Our Team
We're Hiring